Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF

BMC Infectious Diseases(2021)10.1186/s12879-021-06296-0Source: DataRank Database

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF is a research paper published in BMC Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.87)OA: goldTopics (115)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Hlaing Thazin Aung,Nicole Besler,Victoria Harris ORCID,Tin Tin Mar,Rebecca E. Colman ORCID

Live enrichment

PubMed:34372793 OpenAlex:https://openalex.org/W3189263648

National Institutes of Health

Grant: 5T32HL134632-02

Training in the Next Generation in Respiratory Science

FWCI

0.87

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-021-06296-0

publisherhttps://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-021-06296-0

publisherhttps://link.springer.com/content/pdf/10.1186/s12879-021-06296-0.pdf

publisherhttps://link.springer.com/article/10.1186/s12879-021-06296-0/fulltext.html

journalhttps://doi.org/10.1186/s12879-021-06296-0

Fields of Study

Tuberculosis Research and EpidemiologyDiagnosis and treatment of tuberculosisDiverse Scientific Research Studies0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AgedAntibiotics, AntitubercularMyanmarFemaleHumansMaleMycobacterium tuberculosisRifampinSensitivity and SpecificityTuberculosisTuberculosis, PulmonarySex DistributionTuberculosis, Multidrug-ResistantDrug Resistance, BacterialYoung Adult

Keywords

RifampicinTuberculosisMedicineMycobacterium tuberculosisMedical microbiologyTropical medicineParasitologyDrug resistanceInternal medicineTransmission (telecommunications)ImmunologyBiologyMicrobiologyPathologyMaleAgingInfectious and parasitic diseasesRC109-216MyanmarRifampin (mesh)Clinical Research (rcdc)Aging (rcdc)Antibiotics0605 Microbiology (for)1103 Clinical Sciences (for)Tuberculosis, Multidrug-Resistant32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Public healthHumans (mesh)Young Adult (mesh)3 Good Health and Well Being (sdg)BacterialPulmonaryMultidrug-ResistantBacterial (mesh)Infection (hrcs-hc)Infectious Diseases6.1 PharmaceuticalsMycobacterium tuberculosis (mesh)HIV/AIDSSexFemaleSensitivity and Specificity (mesh)RifampinInfection570Myanmar (mesh)Clinical SciencesXpert MTB/RIF610AntitubercularXpert MTBAntimicrobial Resistance (rcdc)Sensitivity and SpecificityEmerging Infectious Diseases (rcdc)Rare Diseases (rcdc)Young AdultRare DiseasesAgeClinical ResearchBiodefenseDrug Resistance, BacterialHumansBiodefense (rcdc)Sex DistributionAntibiotics, AntitubercularTuberculosis, Pulmonary3202 Clinical Sciences (for-2020)Tuberculosis (mesh)AgedAntitubercular (mesh)HIV/AIDS (rcdc)6.1 Pharmaceuticals (hrcs-rac)RIFBiomedical and Clinical SciencesAged (mesh)Research1108 Medical Microbiology (for)Rifampicin resistance3207 Medical microbiology (for-2020)Emerging Infectious DiseasesGood Health and Well Being4206 Public health (for-2020)Infectious Diseases (rcdc)Female (mesh)Multidrug-Resistant (mesh)Microbiology (science-metrix)Pulmonary (mesh)Sexually Transmitted InfectionsAntimicrobial ResistanceTuberculosis (rcdc)Sex Distribution (mesh)Sexually Transmitted Infections (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being